Publications

This study shows MyoStress was non-inferior to CMR stress testing, with a comparable ability to diagnose and risk stratify CAD patients. This test offers advantages in speed, ease and reproducibility, creating an opportunity for a rapid, cost-effective stress test that gives physicians the ability to evaluate patients efficiently.

This publication evaluates the use of various cardiac imaging techniques in the diagnostic work-up for patients with suspected cardiac amyloidosis, which often presents similarly to other conditions. MyoStrain was able to differentiate and identify cardiac amyloidosis patients, offering a comprehensive evaluation in just a single examination. The ability to diagnose early is crucial to improving cardiac amyloidosis patient outcomes, and MyoStrain’s ability to detect subclinical dysfunction sets it apart from other imaging techniques.

Results from this publication demonstrated MyoStrain’s accuracy and reproducibility for the detection of cardiac dysfunction across multiple disease states. This highlights MyoStrain's clinical utility in identifying patients in need of care based on the extent and severity of subclinical dysfunction.

This publication showcases MyoStrain’s promising clinical utility as a sensitive tool to detect early heart dysfunction over traditional testing methods, irrespective of disease type.

This study indicates that in patients presenting with acute chest pain and inconclusive initial clinical screening, MyoStrain can be used to rule out obstructive coronary artery disease. These results show that MyoStrain may serve as a fast and accurate diagnostic tool that could be integrated into clinical workflows.

MyoStrain revealed that the LV septum is the location affected most, with reduced values visible in HFpEF and further reductions in HFmrEF and HFrEF where traditional CMR did not detect. This may hold significant socioeconomic implications, possibly aiding the identification of millions of presumable healthy individuals at risk for heart failure, who could benefit from early risk control and treatment.

This paper evaluates the accuracy, consistency, and reproducibility of MyoStrain in the assessment of left ventricular function. Authors compared global and segmental strain measurements acquired using MyoStrain (fast-SENC), predecessor technology myocardial tagging, and feature tracking.

In this article, MyoStrain provides a rapid and quantitative assessment of segmental myocardial strain to help reliably detect ischemia in patients suspected in coronary artery disease.

In this abstract, authors utilize MyoStrain's non-invasive hyperventilation stress test to help physicians detect ischemic coronary artery disease in chest pain patients entering the ER.